Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 193
8
Diseases
56
Unique genes
0.049
Avg. similarity score
Ovarian cysts
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Ovarian cysts
Amenorrhea
Congenital adrenal hyperplasia
Bosch-boonstra-schaaf optic atrophy syndrome
Cataract-growth hormone deficiency-skeletal dysplasia syndrome
Isolated follicle-stimulating hormone deficiency
amyotrophic lateral sclerosis type 9
immunodeficiency, common variable, 5
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Ovarian cysts | 5 | 5 | 35 |
| Amenorrhea | 2 | 2 | 15 |
| Congenital adrenal hyperplasia | 2 | 2 | 11 |
| Bosch-boonstra-schaaf optic atrophy syndrome | 1 | 1 | 1 |
| Cataract-growth hormone deficiency-skeletal dysplasia syndrome | 1 | 1 | 1 |
| Isolated follicle-stimulating hormone deficiency | 1 | 1 | 1 |
| amyotrophic lateral sclerosis type 9 | 1 | 1 | 1 |
| immunodeficiency, common variable, 5 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| CYP17A1 | 3 / 8 | Amenorrhea, Congenital adrenal hyperplasia, Ovarian cysts |
| ANG | 2 / 8 | amyotrophic lateral sclerosis type 9, Ovarian cysts |
| CYP19A1 | 2 / 8 | Amenorrhea, Congenital adrenal hyperplasia |
| FSHB | 2 / 8 | Amenorrhea, Isolated follicle-stimulating hormone deficiency |
| IARS2 | 2 / 8 | Cataract-growth hormone deficiency-skeletal dysplasia syndrome, Ovarian cysts |
| MS4A1 | 2 / 8 | immunodeficiency, common variable, 5, Ovarian cysts |
| MSH2 | 2 / 8 | Congenital adrenal hyperplasia, Ovarian cysts |
| NR2F1 | 2 / 8 | Bosch-boonstra-schaaf optic atrophy syndrome, Ovarian cysts |
| POR | 2 / 8 | Amenorrhea, Congenital adrenal hyperplasia |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Cortisol synthesis and secretion | KEGG | 8 / 65 | 26.4× | 5.46e-10 | 6.57e-8 ✓ sig. |
| Ovarian steroidogenesis | KEGG | 7 / 52 | 28.9× | 3.70e-9 | 3.61e-7 ✓ sig. |
| Glucocorticoid biosynthesis | Reactome | 4 / 10 | 85.8× | 8.72e-8 | 5.82e-6 ✓ sig. |
| Steroid hormone biosynthesis | KEGG | 6 / 63 | 20.4× | 4.32e-7 | 2.36e-5 ✓ sig. |
| Endogenous sterols | Reactome | 4 / 25 | 34.3× | 4.99e-6 | 1.90e-4 ✓ sig. |
| Cushing syndrome | KEGG | 7 / 155 | 9.7× | 7.11e-6 | 2.52e-4 ✓ sig. |
| Aldosterone synthesis and secretion | KEGG | 5 / 98 | 10.9× | 8.97e-5 | 2.05e-3 ✓ sig. |
| Mineralocorticoid biosynthesis | Reactome | 2 / 6 | 71.5× | 3.17e-4 | 5.59e-3 ✓ sig. |
| Androgen biosynthesis | Reactome | 2 / 11 | 39.0× | 1.14e-3 | 1.50e-2 ✓ sig. |
| Pregnenolone biosynthesis | Reactome | 2 / 12 | 35.7× | 1.37e-3 | 1.72e-2 ✓ sig. |
| ADORA2B mediated anti-inflammatory cytokines production | Reactome | 4 / 128 | 6.7× | 2.95e-3 | 3.04e-2 ✓ sig. |
| Hormone signaling | KEGG | 5 / 219 | 4.9× | 3.46e-3 | 3.40e-2 ✓ sig. |
| G alpha (s) signalling events | Reactome | 4 / 140 | 6.1× | 4.06e-3 | 3.81e-2 ✓ sig. |
| Prolactin signaling pathway | KEGG | 3 / 71 | 9.1× | 4.39e-3 | 4.02e-2 ✓ sig. |
| Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4) | Reactome | 1 / 1 | 214× | 4.66e-3 | 4.18e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| steroid biosynthetic process | GO:0006694 | 7 / 65 | 35.9× | 8.96e-10 | 2.03e-7 ✓ sig. |
| glucocorticoid biosynthetic process | GO:0006704 | 4 / 7 | 191× | 2.51e-9 | 5.05e-7 ✓ sig. |
| cortisol biosynthetic process | GO:0034651 | 3 / 5 | 200× | 2.54e-7 | 2.65e-5 ✓ sig. |
| sterol metabolic process | GO:0016125 | 4 / 22 | 60.7× | 5.08e-7 | 4.74e-5 ✓ sig. |
| cellular response to peptide hormone stimulus | GO:0071375 | 3 / 18 | 55.6× | 2.01e-5 | 9.03e-4 ✓ sig. |
| cortisol metabolic process | GO:0034650 | 2 / 4 | 167× | 5.27e-5 | 1.88e-3 ✓ sig. |
| C21-steroid hormone biosynthetic process | GO:0006700 | 2 / 5 | 133× | 8.77e-5 | 2.74e-3 ✓ sig. |
| positive regulation of gene expression | GO:0010628 | 8 / 504 | 5.3× | 1.21e-4 | 3.48e-3 ✓ sig. |
| lipid metabolic process | GO:0006629 | 10 / 840 | 4.0× | 1.73e-4 | 4.56e-3 ✓ sig. |
| C21-steroid hormone metabolic process | GO:0008207 | 2 / 7 | 95.3× | 1.83e-4 | 4.76e-3 ✓ sig. |
| cholesterol metabolic process | GO:0008203 | 4 / 107 | 12.5× | 2.97e-4 | 6.66e-3 ✓ sig. |
| androgen biosynthetic process | GO:0006702 | 2 / 9 | 74.2× | 3.13e-4 | 6.93e-3 ✓ sig. |
| proteoglycan metabolic process | GO:0006029 | 2 / 11 | 60.7× | 4.77e-4 | 9.29e-3 ✓ sig. |
| response to hormone | GO:0009725 | 3 / 55 | 18.2× | 5.99e-4 | 1.08e-2 ✓ sig. |
| steroid metabolic process | GO:0008202 | 4 / 135 | 9.9× | 7.15e-4 | 1.22e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Amenorrhea | Congenital adrenal hyperplasia | 0.125 | 3 | 1.23e-7 | 9.01e-7 ✓ sig. |
| Congenital adrenal hyperplasia | Ovarian cysts | 0.044 | 2 | 2.73e-4 | 6.71e-4 ✓ sig. |
| Amenorrhea | Isolated follicle-stimulating hormone deficiency | 0.063 | 1 | 9.74e-4 | 1.64e-3 ✓ sig. |
| amyotrophic lateral sclerosis type 9 | Ovarian cysts | 0.028 | 1 | 2.27e-3 | 3.18e-3 ✓ sig. |
| Bosch-boonstra-schaaf optic atrophy syndrome | Ovarian cysts | 0.028 | 1 | 2.27e-3 | 3.18e-3 ✓ sig. |
| Cataract-growth hormone deficiency-skeletal dysplasia syndrome | Ovarian cysts | 0.028 | 1 | 2.27e-3 | 3.18e-3 ✓ sig. |
| immunodeficiency, common variable, 5 | Ovarian cysts | 0.028 | 1 | 2.27e-3 | 3.18e-3 ✓ sig. |